Stephanie R Edmondson

发表论文 6 篇 · 总被引 9 次 · h-index 2

代表论文

• Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors. (2025 · Journal of Clinical Oncology · 被引 6)
• Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (DEP CTX) in patients with advanced solid cancers in a phase 1/2 trial (P1/2). (2024 · Journal of Clinical Oncology · 被引 3)
• Dendrimer-nanoparticle (DEP) delivery of cabazitaxel (DEP-cabazitaxel): A first-in-human phase 1/2 trial in patients with advanced solid tumours. (2026 · European Journal of Cancer · 被引 1)
• Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial. (2024 · Journal of Clinical Oncology · 被引 1)
• Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial. (2024 · Journal of Clinical Oncology)
• Abstract B039: A phase 1/2 study of dendrimer-enhanced (DEP) SN38 (SN38-SPL9111/DEP irinotecan) in patients with advanced solid tumours (2023 · Molecular Cancer Therapeutics)